injection drug use (IDU) in order to inform health care policy. METHODS: Systematic review of the literature identified articles with information on the mean duration of infection and the prevalence of cirrhosis for those who obtained HCV infection through IDU. Data on mean age, mean alanine aminotransferase (ALT) enzyme levels, proportion male, proportion with HIV co-infection, proportion with alcohol abuse, and study setting (academic liver clinic, community-based clinic or addiction therapy) were abstracted. Summary progression rates were estimated using random effects Poisson meta-regression, fitted with WinBUGS software. Uninformative prior distributions were used. The impact of study co-variates on the progression rate was assessed by estimating the posterior probability that the relative risk (RR) exceeds 1.0. RESULTS: Systematic review identified 5225 abstracts. Abstract review identified 459 relevant articles and a total of 41 articles met the inclusion criteria. Each of the 41 studies had a retrospective study design. The progression rate estimate (adjusted for all co-variates) was 11.2 per 1000 personyears (95% Credible Region, 4.9 to 27.2 per 1000 person-years) corresponding to a 20-year cirrhosis prevalence of 20.2% for patients with chronic HCV infection, in a community-based clinic/addiction therapy setting, in which patients at advanced stage of disease are excluded. Faster progression was associated with a greater proportion male and a greater proportion with alcohol abuse, but not a greater proportion co-infected with HIV (probability RR > 1 = 0.90, 0.84, and 0.56, respectively). Two studies (one with a large sample size) that demonstrated no difference in prognosis associated with HIV co-infection may explain this counterintuitive result. CONCLUSION: Progression rate estimates for patients who contracted HCV through substance abuse are similar to estimates derived from posttransfusion or liver clinic cohorts. Kroger Pharmacy, Louisville, KY, USA OBJECTIVE: Patients seen in a hospital emergency department (ED) require acute care. There is no time to culture an infection for a specific antibiotic. Therefore, broad spectrum antibiotics are used most commonly for the unknown infections. It is the purpose of this project to examine physician choices of antibiotics, and the patient conditions for which they are prescribed. METHODS: Data was collected in a mid-sized, urban hospital for a six month period. All antibiotics prescribed to the patients during this time period were recorded, a total of approximately 3100 prescriptions. Because the patients have very different complaints in the ED, it is difficult to isolate specific diagnoses to determine whether different diagnoses result in different antibiotic prescriptions. To handle this problem, we reduce the patient diagnoses to ten clusters to determine whether there is uniformity of prescribing within the clusters. RESULTS: Levaquin was prescribed for approximately 40% of the patients receiving antibiotics in the hospital ED followed by Azithromycin and Cefotaxime at 10%. Vancomycin was used for 8% of the antibiotic prescriptions as was Piperacillin/Taxobactam (Zosyn). However, the prescriptions were not uniform across physicians. In particular, one physician favored Zosyn over Levaquin while another used as much Cipro as Levaquin. A total of eight antibiotics account for 96% of the total use. Two of the least used include Linezolid and Tobramycin, both of which are expensive and should have a definite culture to support use. Although physicians differed considerably in their prescribing habits, there was no statistical difference in the patient conditions treated. CONCLUSION: Different physicians have different antibiotic prescribing habits. It is important to examine the prescribing to reach a consensus of best practices in the ED. Due to the increasing costs for antibiotics and increasing resistance in Slovakia the educative project S-MedDial was established in the cooperation with professional companies, under the guarantee of the General Health Insurance Fund. The project evaluates prescription habits in respiratory infections, monitors antibiotics resistance for main bacterial pathogens and provides individual feedback to paediatrists with the aim to rationalize the antibiotics prescription and to decrease the resistance risk. METHODS: Antibiotic prescription habits were analysed from 2003 to 2006 for 73 doctors in 5 region based on both the prospective data from protocols (14537 protocols in y.2006) and the retrospective claims insurance data. Analysis was based on the established comparison system of prescription profiles and individual feedback was provided to each practitioner during regional meetings of project members. RESULTS: Every second child with respiratory infection was treated with antibiotics. In the whole patient group the most frequently indicated drugs were macrolides (25.9%), followed by basic penicillins (20.4%) and penicillins potentiated with beta-lactamase inhibitors (19.9%). Macrolides were most frequently prescribed in region Bratislava (37.3%) and Nitra (35.4%). In region Presov there were aminopenicillins potentiated with beta-lactamase inhibitors indicated mostly (22.5%), in Trebisov broad-spectrum penicillins (28.4%) and in Zvolen basic penicillins (30%). From macrolides the most frequently prescribed was azitromycin followed by claritromycin. In all cooperating regions the antibiotics costs were reduced by 5.1% per patient. Significant differences in antibiotics prescription in regions were not only in the number of indicated antibiotics but also in their spectrum. The usage of antibiotics in the prospective study was decrease the most in Presov, from 67.8 % to 49.6%. CONCLUSION: S-MedDial project represents an option for increase of antibiotics prescription quality while using the prescribing practitioners' education. Analysis of antibiotics prescription habits is suitable not only for cost control but also for antibiotics prescription implications on resistance trends.
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